Efficacy and Safety of Fluticasone Furoate/Vilanterol Compared With Fluticasone Propionate/Salmeterol Combination in Adult and Adolescent Patients With Persistent Asthma: A Randomized Trial

BACKGROUND: The combination of fluticasone furoate (FF), a novel inhaled corticosteroid (ICS), and vilanterol (VI), a long-acting β(2) agonist, is under development as a once-daily treatment of asthma and COPD. The aim of this study was to compare the efficacy of FF/VI with fluticasone propionate (F...

Descripción completa

Detalles Bibliográficos
Autores principales: Woodcock, Ashley, Bleecker, Eugene R., Lötvall, Jan, O’Byrne, Paul M., Bateman, Eric D., Medley, Hilary, Ellsworth, Anna, Jacques, Loretta, Busse, William W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Chest Physicians 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787916/
https://www.ncbi.nlm.nih.gov/pubmed/23846316
http://dx.doi.org/10.1378/chest.13-0178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787916/
https://www.ncbi.nlm.nih.gov/pubmed/23846316
http://dx.doi.org/10.1378/chest.13-0178

Ejemplares similares